CAPRICOR THERAPEUTICS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
CAPRICOR THERAPEUTICS, INC. (CAPR) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $31.80 million as of 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-03-17
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $31.80M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $35.00M.
- 2025-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $37.90M.
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $39.20M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2025-12-31 | $31.80M 10-K · filed 2026-03-17 |
| 2025-09-30 | $35.00M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $37.90M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $39.20M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $20.40M 10-K · filed 2025-03-26 |
| 2024-09-30 | $16.60M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $19.20M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $21.20M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $13.50M 10-K · filed 2024-03-11 |
| 2023-09-30 | $14.40M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $13.70M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $15.20M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $10.10M 10-K · filed 2023-03-17 |
| 2022-09-30 | $11.60M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $12.70M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $12.40M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $7.70M 10-K · filed 2022-03-11 |
| 2021-09-30 | $8.50M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $8.40M 10-Q · filed 2021-08-13 |
| 2020-12-31 | $5.70M 10-K · filed 2021-03-15 |
| 2020-09-30 | $171.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $171.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $171.00K 10-K · filed 2022-03-11 |
| 2019-12-31 | $800.00K 10-K · filed 2020-03-27 |
| 2018-12-31 | $1.40M 10-K · filed 2019-03-29 |
| 2017-12-31 | $2.40M 10-K · filed 2018-03-22 |
| 2016-12-31 | $3.50M 10-K · filed 2017-03-16 |
| 2016-06-30 | $4.60M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $3.90M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $4.20M 10-K · filed 2016-03-30 |
| 2015-09-30 | $4.80M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $4.60M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $4.50M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $1.70M 10-K · filed 2015-03-16 |
| 2014-09-30 | $1.80M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $1.30M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $828.03K 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |